Skip to content

Control of bleeding caused by the use of angiography in powder celox

Comparison study of Celox powder and standard dressing in control of bleeding from coronary angiography location in Shahid Beheshti Hospital of Qom during 2012

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201202209084N1
Enrollment
100
Registered
2012-07-26
Start date
2012-04-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury, poisoning and certain other consequences of external causes. Injuries to the hip and thigh

Interventions

Intervention 1: The patients of case group will receive 2gr Celox powder, made by MedTrade Products Ltd on the angiography location and then hand pressure will be performed. Age, gender, time to stop
Treatment - Drugs
Treatment - Other
The patients of case group will receive 2gr Celox powder, made by MedTrade Products Ltd on the angiography location and then hand pressure will be performed. Age, gender, time to stop bleeding, underl
The patients of control group will receive standard dressing on the angiography location and then hand pressure will be performed. Age, gender, time to stop bleeding, underlying disease, anticoagulati

Sponsors

Vice chancellor for Education, Research and Technology of Qom University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Personal satisfaction of patients, patients candidates for coronary angiography for diagnosis or treatment (angioplasty) Exclusion criteria: Lack of personal satisfaction of patients for using celox powder, severe skin allergy

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

MeasureTime frame
The severity of andiography location's pain. Timepoint: 6 hours after stopping bleeding. Method of measurement: With 5 degree Likert scale.;Hematoma. Timepoint: 1 hour and 6 hours after stopping bleeding. Method of measurement: Observation of Edema and palpation of angiography location.

Primary

MeasureTime frame
Hemostasis. Timepoint: Till stopping bleeding. Method of measurement: With Cronometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahid Damanpak

Qom University of Medical Sciences

vdamanpak@muq.ac.ir+98 25 1612 2952

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026